Stocks and Investing Stocks and Investing
Wed, August 10, 2022

Andrew Fein Maintained (TARA) at Strong Buy with Decreased Target to $23 on, Aug 10th, 2022


Published on 2024-10-27 22:33:47 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Maintained "Protara Therapeutics, Inc." (TARA) at Strong Buy with Decreased Target from $30 to $23 on, Aug 10th, 2022.

Andrew, nor any peers, have made any analyst calls on TARA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources